Evidence map›Paper›PMID 33917893›Full record

ArticleBrain sciences2021

Transcutaneous Spinal Cord Stimulation Enhances Walking Performance and Reduces Spasticity in Individuals with Multiple Sclerosis.

Ursula S Hofstoetter, Brigitta Freundl, Peter Lackner, Heinrich Binder

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06012110 (Transcutaneous Electrical Stimulation for Spasticity in Patients With Primary Lateral Sclerosis), which is not on this map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06012110 nacompletednot on this mapstarted 2023, after this paper: background citation

Transcutaneous Electrical Stimulation for Spasticity in Patients With Primary Lateral Sclerosis

TypeinterventionalSponsorNova Southeastern UniversityRan2023 to 2024Enrolled6ConditionsPrimary Lateral SclerosisArmsTranscutaneous electrical stimulation
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ursula S HofstoetterCenter for Medical Physics and Biomedical Engineering, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3156-6483
Brigitta FreundlNeurological Center, Klinik Penzing-Wiener Gesundheitsverbund, 1140 Vienna, Austria.
Peter LacknerNeurological Center, Klinik Penzing-Wiener Gesundheitsverbund, 1140 Vienna, Austria.
Heinrich BinderNeurological Center, Klinik Penzing-Wiener Gesundheitsverbund, 1140 Vienna, Austria.
Wiener Krankenanstaltenverbund · ATMedical University of Vienna · AT

Funding

Austrian Society for Neurorehabilitation (OeGNR) 2017
6 · The paper itself

Abstract

Gait dysfunction and spasticity are common debilitating consequences of multiple sclerosis (MS). Improvements of these motor impairments by lumbar transcutaneous spinal cord stimulation (tSCS) have been demonstrated in spinal cord injury. Here, we explored for the first time the motor effects of lumbar tSCS applied at 50 Hz for 30 min in 16 individuals with MS and investigated their temporal persistence post-intervention. We used a comprehensive protocol assessing walking ability, different presentations of spasticity, standing ability, manual dexterity, and trunk control. Walking ability, including walking speed and endurance, was significantly improved for two hours beyond the intervention and returned to baseline after 24 h. Muscle spasms, clonus duration, and exaggerated stretch reflexes were reduced for two hours, and clinically assessed lower-extremity muscle hypertonia remained at improved levels for 24 h post-intervention. Further, postural sway during normal standing with eyes open was decreased for two hours. No changes were detected in manual dexterity and trunk control. Our results suggest that transcutaneous lumbar SCS can serve as a clinically accessible method without known side effects that holds the potential for substantial clinical benefit across the disability spectrum of MS.

Indexed as

gait dysfunctionhumanmultiple sclerosisneuromodulationnon-invasivespasticityspinal cord stimulationstanding abilitytranscutaneouswalking function

Identifiers

PMID33917893
PMCPMC8068213
OpenAlexW3155718621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.